Clinical

College Students’ Perceptions About Prescription Drug Misuse Among Peers

Chibuzo Iloabuchi, BPharm; Eiman Aboaziza, MD; Xiaohui Zhao, MS, PhD; J. Douglas Thornton, PhD, PharmD, BCPS; Nilanjana Dwibedi, BPharm, MBA, PhD

Clinical, Review Article

Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet

Jack E. Fincham, PhD, RPh

Clinical, Original Research

Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure

Chi Nguyen, PhD; Xian Zhang, PhD; Thomas Evers, PhD; Vincent J. Willey, PharmD; Hiangkiat Tan, MS, BPharm; Thomas P. Power, MD, FACC, MRCPI

Clinical, Original Research

A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making

Madison M. Wempe, BS; Mark D. Stewart, PhD; Daniel Glass, PhD; Laura Lasiter, PhD; Diana Merino Vega, PhD; Nisha Ramamurthy; Jeff Allen, PhD; Ellen V. Sigal, PhD

Stakeholder Perspective

Navigating the Complex World of Diagnostic Tests and Their Role in Clinical Decision-Making

James T. Kenney, RPh, MBA

Clinical, Original Research

Mental Health Conditions and Hospitalizations for Ambulatory Care Sensitive Conditions Among Veterans with Diabetes

Drew A. Helmer, MD, MS; Nilanjana Dwibedi, BPharm, MBA, PhD; Mazhgan Rowneki, MPH; Chin-Lin Tseng, DrPH; Dennis Fried, PhD; Danielle Rose, PhD; Nisha Jani, MPH, PhD; Usha Sambamoorthi, PhD

Stakeholder Perspective

Mental Health Conditions Constitute Significant Comorbidity: The Impact on Potentially Avoidable Hospital Admissions

Gary M. Owens, MD

Clinical, Original Research

Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan

Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD

Stakeholder Perspective

Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence

F. Randy Vogenberg, PhD, FASHP

Clinical, Original Research

Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis

Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS

Clinical, Original Article

Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System

Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS

Stakeholder Perspective

Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases

F. Randy Vogenberg, RPh, PhD, FASHP

Clinical, Original Research

Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus

Pragya Rai, MS; Nilanjana Dwibedi, PhD; Mazhgan Rowneki, MPH; Drew A. Helmer, MD, MS; Usha Sambamoorthi, PhD

Stakeholder Perspective

Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes

Priya Nileshwar, DO; Quang Nguyen, DO, FACE, FTOS

Clinical, Original Research

Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation

William P. Glasheen, PhD; Tristan Cordier, MPH; Rajiv Gumpina, MS; Gil Haugh, MS; Jared Davis, MD, MBA; Andrew Renda, MD, MPH

Page 1 of 14
Results 1 - 10 of 135